Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab

Lorenzo Dagna, Angelo Corti, Silvia Langheim, Barbara Guglielmi, Francesco De Cobelli, Claudio Doglioni, Gabriele Fragasso, Maria Grazia Sabbadini, Marina Ferrarini

Research output: Contribution to journal › Article

58 Citations (Scopus)
Original languageEnglish
JournalJournal of Clinical Oncology
Volume30
Issue number28
DOIs
Publication statusPublished - Oct 1 2012

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease : Rationale for the treatment of patients with infliximab. / Dagna, Lorenzo; Corti, Angelo; Langheim, Silvia; Guglielmi, Barbara; De Cobelli, Francesco; Doglioni, Claudio; Fragasso, Gabriele; Sabbadini, Maria Grazia; Ferrarini, Marina.

In: Journal of Clinical Oncology, Vol. 30, No. 28, 01.10.2012.

Research output: Contribution to journal › Article

Dagna, L, Corti, A, Langheim, S, Guglielmi, B, De Cobelli, F, Doglioni, C, Fragasso, G, Sabbadini, MG & Ferrarini, M 2012, 'Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab', Journal of Clinical Oncology, vol. 30, no. 28. https://doi.org/10.1200/JCO.2012.41.9911
Dagna L, Corti A, Langheim S, Guglielmi B, De Cobelli F, Doglioni C et al. Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab. Journal of Clinical Oncology. 2012 Oct 1;30(28). https://doi.org/10.1200/JCO.2012.41.9911
Dagna, Lorenzo ; Corti, Angelo ; Langheim, Silvia ; Guglielmi, Barbara ; De Cobelli, Francesco ; Doglioni, Claudio ; Fragasso, Gabriele ; Sabbadini, Maria Grazia ; Ferrarini, Marina. / Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease : Rationale for the treatment of patients with infliximab. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 28.
@article{1e978aad4a2f4887b1e994bb6f5ffa44,
title = "Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab",
author = "Lorenzo Dagna and Angelo Corti and Silvia Langheim and Barbara Guglielmi and {De Cobelli}, Francesco and Claudio Doglioni and Gabriele Fragasso and Sabbadini, {Maria Grazia} and Marina Ferrarini",
year = "2012",
month = "10",
day = "1",
doi = "10.1200/JCO.2012.41.9911",
language = "English",
volume = "30",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "28",

}

TY - JOUR

T1 - Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease

T2 - Rationale for the treatment of patients with infliximab

AU - Dagna, Lorenzo

AU - Corti, Angelo

AU - Langheim, Silvia

AU - Guglielmi, Barbara

AU - De Cobelli, Francesco

AU - Doglioni, Claudio

AU - Fragasso, Gabriele

AU - Sabbadini, Maria Grazia

AU - Ferrarini, Marina

PY - 2012/10/1

Y1 - 2012/10/1

UR - http://www.scopus.com/inward/record.url?scp=84867083505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867083505&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.41.9911

DO - 10.1200/JCO.2012.41.9911

M3 - Article

C2 - 22869874

AN - SCOPUS:84867083505

VL - 30

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 28

ER -

Access to Document